Literature DB >> 23648379

Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.

Nelson G Ordóñez1.   

Abstract

Since the identification of S100 protein as an immunohistochemical marker that could be useful in the diagnosis of melanoma in the early 1980s, a large number of other melanocytic-associated markers that could potentially be used to assist in the differential diagnosis of these tumors have also been investigated. A great variation exists, however, among these markers, not only in their expression in some subtypes of melanoma, particularly desmoplastic melanoma, but also in their specificity because some of them can also be expressed in nonmelanocytic neoplasms, including various types of soft tissue tumors and carcinomas. This article reviews the information that is currently available on the practical value of some of the markers that have more often been recommended for assisting in the diagnosis of melanomas, including those that have only recently become available.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; KBA.62; Melan A; Melanoma; Microphthalmia transcription factor; PNL2; SOX10; Tyrosinase

Mesh:

Substances:

Year:  2013        PMID: 23648379     DOI: 10.1016/j.humpath.2013.02.007

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  27 in total

1.  Metastatic melanoma mimicking solitary fibrous tumor: report of two cases.

Authors:  Elise M Bekers; Adriana C H van Engen-van Grunsven; Patricia J T A Groenen; Harm Westdorp; Rutger H T Koornstra; Johannes J Bonenkamp; Uta Flucke; Willeke A M Blokx
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

2.  A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

Authors:  Ahmad A Tarhini; Theofanis Floros; Hui-Min Lin; Yan Lin; Zahra Rahman; Madeeha Ashraf; Priyanka Vallabhaneni; Cindy Sander; Uma N M Rao; Monica Panelli; William A LaFramboise; John M Kirkwood
Journal:  Melanoma Res       Date:  2017-10       Impact factor: 3.599

3.  MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.

Authors:  I Made Winarsa Ruma; Endy Widya Putranto; Eisaku Kondo; Hitoshi Murata; Masami Watanabe; Peng Huang; Rie Kinoshita; Junichiro Futami; Yusuke Inoue; Akira Yamauchi; I Wayan Sumardika; Chen Youyi; Ken-Ichi Yamamoto; Yasutomo Nasu; Masahiro Nishibori; Toshihiko Hibino; Masakiyo Sakaguchi
Journal:  Clin Exp Metastasis       Date:  2016-05-05       Impact factor: 5.150

4.  Lipoblast-Like Morphology in a Uveal Melanoma with Delayed Metastasis to the Liver.

Authors:  Aimi Toyama; W Robert Bell; Alessio Giubellino; Faqian Li
Journal:  Ocul Oncol Pathol       Date:  2019-09-04

5.  BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors.

Authors:  Deon B Doxie; Allison R Greenplate; Jocelyn S Gandelman; Kirsten E Diggins; Caroline E Roe; Kimberly B Dahlman; Jeffrey A Sosman; Mark C Kelley; Jonathan M Irish
Journal:  Pigment Cell Melanoma Res       Date:  2018-06-28       Impact factor: 4.693

Review 6.  Investigation of cAMP microdomains as a path to novel cancer diagnostics.

Authors:  Garrett Desman; Caren Waintraub; Jonathan H Zippin
Journal:  Biochim Biophys Acta       Date:  2014-09-07

7.  uPAR+ extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients.

Authors:  Letizia Porcelli; Michele Guida; Simona Serratì; Amalia Azzariti; Simona De Summa; Roberta Di Fonte; Ivana De Risi; Marianna Garofoli; Mariapia Caputo; Antonio Negri; Sabino Strippoli
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

8.  The multifaceted role of CD146/MCAM in the promotion of melanoma progression.

Authors:  Xing Lei; Ce-Wen Guan; Yang Song; Huan Wang
Journal:  Cancer Cell Int       Date:  2015-02-04       Impact factor: 5.722

Review 9.  Emerging clinical applications of selected biomarkers in melanoma.

Authors:  Michael T Tetzlaff; Carlos A Torres-Cabala; Penvadee Pattanaprichakul; Ronald P Rapini; Victor G Prieto; Jonathan L Curry
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-01-30

10.  Functional in vivo characterization of sox10 enhancers in neural crest and melanoma development.

Authors:  Rebecca L Cunningham; Eva T Kramer; Sophia K DeGeorgia; Paula M Godoy; Anna P Zarov; Shayana Seneviratne; Vadim Grigura; Charles K Kaufman
Journal:  Commun Biol       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.